These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 6850526)

  • 21. Barriers to acceptance of controlled phase III clinical trials: behavioral factors.
    Spodick DH
    Biomed Pharmacother; 1983; 37(2):60-1. PubMed ID: 6616031
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The impact of clinical trial protocols on patient care in a community hospital.
    McKenna RJ
    Cancer; 1993 Nov; 72(9 Suppl):2828-33. PubMed ID: 8402513
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The physician manager--building a clinical leadership in community medicine--the Maccabi Healthcare Services (MHS) model].
    Kokia E; Siegal N; Shemer J
    Harefuah; 2008 May; 147(5):445-8, 476. PubMed ID: 18770969
    [TBL] [Abstract][Full Text] [Related]  

  • 24. National Cancer Institute's Precision Medicine Initiatives for the new National Clinical Trials Network.
    Abrams J; Conley B; Mooney M; Zwiebel J; Chen A; Welch JJ; Takebe N; Malik S; McShane L; Korn E; Williams M; Staudt L; Doroshow J
    Am Soc Clin Oncol Educ Book; 2014; ():71-6. PubMed ID: 24857062
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ethical pitfalls in neonatal comparative effectiveness trials.
    Modi N
    Neonatology; 2014; 105(4):350-1. PubMed ID: 24931328
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Some thoughts on the future of clinical trials groups in cancer.
    Taylor KM; Shapiro M; Skinner HA
    Cancer Treat Rep; 1987 Apr; 71(4):434-5. PubMed ID: 3829020
    [No Abstract]   [Full Text] [Related]  

  • 27. Clinical cancer advances 2011: Annual Report on Progress Against Cancer from the American Society of Clinical Oncology.
    Vogelzang NJ; Benowitz SI; Adams S; Aghajanian C; Chang SM; Dreyer ZE; Janne PA; Ko AH; Masters GA; Odenike O; Patel JD; Roth BJ; Samlowski WE; Seidman AD; Tap WD; Temel JS; Von Roenn JH; Kris MG
    J Clin Oncol; 2012 Jan; 30(1):88-109. PubMed ID: 22147736
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Designing for cancer clinical trials: selection of prognostic factors.
    Brown BW
    Cancer Treat Rep; 1980; 64(2-3):499-502. PubMed ID: 7407790
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The four community dimensions of primary care practice.
    Pathman DE; Steiner BD; Williams E; Riggins T
    J Fam Pract; 1998 Apr; 46(4):293-303. PubMed ID: 9564371
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Allocation of treatment to patients when not all balancing factors are known to the co-ordinating centre.
    van Lier HJ; van Elteren P; Hoitsma AJ; Koene RA
    Stat Med; 1984; 3(3):219-24. PubMed ID: 6385188
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Oncologists' reluctance to accrue patients onto clinical trials: an Illinois Cancer Center study.
    Benson AB; Pregler JP; Bean JA; Rademaker AW; Eshler B; Anderson K
    J Clin Oncol; 1991 Nov; 9(11):2067-75. PubMed ID: 1941065
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The role of the nurse in clinical cancer research.
    Cassidy J; Macfarlane DK
    Cancer Nurs; 1991 Jun; 14(3):124-31. PubMed ID: 2059955
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Quality of patient care by nurse practitioners and physician's assistants: a ten-year perspective.
    Sox HC
    Ann Intern Med; 1979 Sep; 91(3):459-68. PubMed ID: 38721
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The dual role of the physician: medicine and research].
    Freud-Silverberg M; Ben David L; Rabin S; Wainstein J
    Harefuah; 2014 Feb; 153(2):101-3, 126, 125. PubMed ID: 24716428
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Accrual of patients into a multihospital cancer clinical trial and its implications on planning future studies.
    Martin JF; Henderson WG; Zacharski LR; Rickles FR; Forman WB; Cornell CJ; Forcier RJ; Edwards RL; Headley E; Kim SH
    Am J Clin Oncol; 1984 Apr; 7(2):173-82. PubMed ID: 6702720
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Why do - or don't - patients with urinary tract infection participate in a clinical trial? A qualitative study in German family medicine.
    Bleidorn J; Bucak S; Gágyor I; Hummers-Pradier E; Dierks ML
    Ger Med Sci; 2015; 13():Doc17. PubMed ID: 26512232
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Community Clinical Oncology Program (CCOP) story: review of community oncologists' experiences with clinical research trials in cancer with an emphasis on the CCOP of the National Cancer Institute between 1982 and 1987.
    Frelick RW
    J Clin Oncol; 1994 Aug; 12(8):1718-23. PubMed ID: 8040683
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Physician's role in the society].
    Solmesky S
    Rev Med Chil; 1993 Apr; 121(4):452-5. PubMed ID: 8272621
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Patients and physicians as obstacles to a randomized trial.
    Lacher MJ
    Semin Oncol; 1981 Dec; 8(4):424-9. PubMed ID: 7323814
    [No Abstract]   [Full Text] [Related]  

  • 40. Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke.
    Higashida RT; Furlan AJ; Roberts H; Tomsick T; Connors B; Barr J; Dillon W; Warach S; Broderick J; Tilley B; Sacks D; ;
    Stroke; 2003 Aug; 34(8):e109-37. PubMed ID: 12869717
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.